Fact CheckerSign in

NCT06884579Completed

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study

Source: ClinicalTrials.gov · Last updated 30 Sept 2026

Brief summary (registry, in English)

This phase of the project aims to compare in-person, supervised educational programs (EP) with online self-guided EPs in individuals with relapsing-remitting multiple sclerosis. A total of 75 participants will be randomly assigned to one of three groups: a supervised and individualized educational program focused on HIIT training, a supervised and individualized educational program focused on strength training, and a non-supervised, self-guided educational program based on resistance band training. Additionally, sessions on the Mediterranean diet (both supervised and non-supervised) and cognitive-behavioral interventions will be included. A control evaluation will be conducted three months after the intervention to assess the effects of the educational programs, followed by another evaluation three months later to analyze residual effects. Women who participated in Phase 1 of the study will be invited to take part in this second phase.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
20 Feb 2025
Start date
15 Apr 2025
Primary completion date
15 Jun 2025
Lead sponsor
Universidad de Almeria
NCT number
NCT06884579

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 15 Apr 2025 to the primary completion date, 15 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • report a relapse within 12 months before the study begins;
  • have taken corticosteroid treatment within the last 2 months;
  • have participated in a structured training program in the previous 6 months.
    • Once all women with MS are recruited, male participants will be recruited following a 1:1 matching methodology based on age, geographic region, and lifestyle habits.

Other

  • score \<1 or \>6 on the EDSS;

Who the study is looking for

  • Women and men of reproductive age (18-45 years) with MS will be included, with the upper age limit adjusted to reflect the reproductive phase;
  • no iron-deficiency anemia;
  • stable disease phase;
  • independent walking ability for over 10 meters.
    • Women will be recruited first and later matched with men based on age, EDSS, and lifestyle habits (physical activity, smoking, and alcohol consumption).

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Universitario Virgen de la Arrixaca
Coordinator of this site? Confirm its status
MurciaSpainUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.